Thinking bigger, Arch Venture closes in on $550M-plus biotech fund
Arch Venture Partners is well along the way to raising a new $550 million-plus fund.
The VC group has posted new forms with the SEC stating that the partners have raised more than $408 million for Arch Venture Fund IX. But it’s unlikely to stop at $550 million. These days, biotech start-up groups like Arch have made it a point of pride to come in over target on the cash. And these partners like to make a splash.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
